SmarterDividends
ABT

Abbott Laboratories

ABT

Healthcare · Stock · quarterly payer

$102.61

Fairly valued · -14% Add to Portfolio

Forward Yield

2.46%

Annual Dividend

$2.52

Payout Ratio

79%

5-Yr Growth

10.4%

Ex-Date

Oct 15, 2026

Frequency

Quarterly

Summary

As of September 2026, Abbott Laboratories (ABT) yields 2.46% ($2.52 per share annually), with a blended fair-value estimate of $88.36 — -14% downside, so it screens as fairly valued. Dividend safety grade: B (75/100). 12 years of dividend growth.

Is ABT a good dividend stock?

Yes

Abbott Laboratories (ABT) pays a quarterly dividend yielding 2.46% ($2.52/yr), with 12 years of growth and a dividend-safety grade of B. It scores well across payout coverage, growth history and safety — a dependable income holding.

Advantages

  • 12 consecutive years of dividend growth
  • Strong 10.4% 5-yr dividend growth

Risks

  • Cut its dividend in 2013
  • Share price is down over the past 5 years

Key Data

Dividend Yield
2.46%
Payout Ratio
79%
Annual Dividend
$2.52
5-Yr Avg Growth
10.4%
Ex-Dividend Date
Oct 15, 2026
Years of Growth
12
Frequency
quarterly
Beta
0.59
Market Cap
$178.7B
P/E Ratio
33.2
5-Yr Total Return
-20%
52-Week Range
$81.97 – $137.49
Dividend Safety
B · 75/100
Ever Cut?
Yes (2013)
ABT ex-dividend date & scheduleNext ex-date Oct 15, 2026 · full ex-dividend historyView →

Frequently Asked Questions